ConductScience.org, home

Paper41566883

Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions.

Odabasi R and 7 others. Adv Healthc Mater, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions. Papers, record 41566883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41566883

Download JSON
Cell line
MDA-MB-231845 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions.
PubMed
Journal
Adv Healthc Mater
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Odabasi RRodi
2Krattiger LALisa A
3Kanari MMagdalini
4Jacobs MAMira A
5Moser LOLukas O
6Tibbitt MWMark W
7Halin CCornelia
8Ehrbar MMartin

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphatic VesselsMajor topic
Breast NeoplasmsMajor topic
BioengineeringMajor topic
Humans
Female
Mesenchymal Stem Cells
Endothelial Cells
Coculture Techniques
Hydrogels
MCF-7 Cells
MDA-MB-231 Cells
Polyethylene Glycols
Lymphangiogenesis
Tissue Scaffolds
Tissue Engineering
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
310030E_202429Swiss National Science FoundationSwitzerlandPubMed
205321_204318Swiss National Science FoundationSwitzerlandPubMed
IZJFZ3_202474Swiss National Science FoundationSwitzerlandPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111489331The physiology of the lymphatic system.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11489331PubMed
217883273Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions.Biomacromolecules2007https://conductscience.org/library/papers/17883273PubMed
337664721Endogenous CCL21-Ser deficiency reduces B16-F10 melanoma growth by enhanced antitumor immunity.Heliyon2023https://conductscience.org/library/papers/37664721PubMed
47836384Purification and characterization of hypoxia-inducible factor 1.J Biol Chem1995https://conductscience.org/library/papers/7836384PubMed
530315324Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources.Cell Mol Life Sci2019https://conductscience.org/library/papers/30315324PubMed
635428014Synthetic hydrogels engineered to promote collecting lymphatic vessel sprouting.Biomaterials2022https://conductscience.org/library/papers/35428014PubMed
730092362Cellular traffic through afferent lymphatic vessels.Vascul Pharmacol2019https://conductscience.org/library/papers/30092362PubMed
840108458Dynamic cytoskeletal regulation of cell shape supports resilience of lymphatic endothelium.Nature2025https://conductscience.org/library/papers/40108458PubMed
936724374Enzymatically Crosslinked Collagen as a Versatile Matrix for In Vitro and In Vivo Co-Engineering of Blood and Lymphatic Vasculature.Adv Mater2023https://conductscience.org/library/papers/36724374PubMed
1030564284Lymphatic Tissue Engineering and Regeneration.J Biol Eng2018https://conductscience.org/library/papers/30564284PubMed
1129984113Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering.Adv Wound Care (New Rochelle)2018https://conductscience.org/library/papers/29984113PubMed
1236415150Engineered models of the lymphatic vascular system: Past, present, and future.Microcirculation2023https://conductscience.org/library/papers/36415150PubMed
1334486138The lymphatic vasculature: An active and dynamic player in cancer progression.Med Res Rev2022https://conductscience.org/library/papers/34486138PubMed
1422811424Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer.Physiol Rev2012https://conductscience.org/library/papers/22811424PubMed
1535534209Buttons and Zippers: Endothelial Junctions in Lymphatic Vessels.Cold Spring Harb Perspect Med2022https://conductscience.org/library/papers/35534209PubMed
1629528507Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.Med Res Rev2018https://conductscience.org/library/papers/29528507PubMed
17345563403D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models.Trends Biotechnol2022https://conductscience.org/library/papers/34556340PubMed
1811175850Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.Nat Med2001https://conductscience.org/library/papers/11175850PubMed
1926622656Breast cancer metastasis and the lymphatic system.Oncol Lett2015https://conductscience.org/library/papers/26622656PubMed
2037811004A 3D Human Lymphatic Vessel-on-Chip Reveals the Roles of Interstitial Flow and VEGF-A/C for Lymphatic Sprouting and Discontinuous Junction Formation.Cell Mol Bioeng2023https://conductscience.org/library/papers/37811004PubMed

See all 49 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42707759Designing the matrix: extracellular matrix-informed strategies for bioengineered cancer models.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42707759PubMed
42655265Structure-Property Evolution of Cubic and Gyroid PLA Scaffolds During In Vitro Degradation Under Physiologically Relevant Conditions.Polymers (Basel)2026https://conductscience.org/library/papers/42655265PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CCL216366PubTator's text mininghttps://conductscience.org/library/genes/6366

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41566883

GET https://conductscience.org/api/papers/v1/41566883/references?page=2